SCHEMBL26032937

SCHEMBL26032937

CCc1cc(N(c2ccccc2)c2ccccc2)cc(N(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26033587 0.88 MAPT (0.36) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL22550709 0.82 ALDH1A1 (0.48) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL26033018 0.78 SIGMAR1 (0.38) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL17051454 0.78 MAPT (0.45) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL26028648 0.77 ALDH1A1 (0.44) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL26028769 0.75 ALDH1A1 (0.45) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL26028657 0.74 ALDH1A1 (0.50) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL23351082 0.71 MAPT (0.41) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL17051456 0.71 ALDH1A1 (0.41) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2
SCHEMBL17051452 0.71 ALDH1A1 (0.41) MAPTALDH1A1TDP1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263047-A1 LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263047-A1 LIGHT EMITTING ELEMENT AND POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT NR2E3, NFE2L2, CRY1 MAPT 3501/4885ALDH1A1 92/4885TDP1 2668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback